Evidence map›Paper›PMID 34581769›Full record

ArticleThe American journal of clinical nutrition2022

Genetic risk for obesity and the effectiveness of the ChooseWell 365 workplace intervention to prevent weight gain and improve dietary choices.

Hassan S Dashti, Douglas E Levy, Marie-France Hivert, Kaitlyn Alimenti, Jessica L McCurley, Richa Saxena, Anne N Thorndike

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A Scoping Review of Choice Architecture to Promote Healthy Nutrition in Health and Care Settings.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hassan S DashtiCenter for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1650-679X
Douglas E LevyMongan Institute Health Policy Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Marie-France HivertDepartment of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Kaitlyn AlimentiCenter for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jessica L McCurleyDivision of General Internal Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Richa SaxenaCenter for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-2233-1065
Anne N ThorndikeDivision of General Internal Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Promoting Employee Health Through The Worksite Food EnvironmentR01HL125486 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI THORNDIKE, ANNE N · 2015 to 2019
$4.0M
Genetics of chronotype and impact on metabolic diseaseR01DK107859 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Richa Saxena · 2016 to 2026
$4.0M
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 DiabetesR01DK102696 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SAXENA, RICHA, SCHEER, FRANK A · 2015 to 2019
$3.8M
Psychological, cognitive, and genetic factors in a behavioral intervention to prevent weight gainR01DK114735 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THORNDIKE, ANNE N · 2017 to 2019
$1.7M
Be Well at Work-Plus: Engaging low-wage workers in the design and implementation of a depression and physical activity intervention - Administrative SupplementK23HL157763 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI MCCURLEY, JESSICA LAUREN · 2021 to 2025
$1.0M
NCATS NIH HHS UL1 TR000170NCATS NIH HHS UL1 TR001102NHLBI NIH HHS K23 HL157763NHLBI NIH HHS R01 HL125486NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK102696NIDDK NIH HHS R01 DK107859NIDDK NIH HHS R01 DK114735
6 · The paper itself

Abstract

backgroundIt is unknown whether behavioral interventions to improve diet are effective in people with a genetic predisposition to obesity.

objectivesTo examine associations between BMI genetic risk and changes in weight and workplace purchases by employees participating in a randomized controlled trial of an automated behavioral workplace intervention to promote healthy food choices.

methodsParticipants were hospital employees enrolled in a 12-mo intervention followed by a 12-mo follow-up. Hospital cafeterias utilized a traffic-light labeling system (e.g., green = healthy, red = unhealthy) that was used to calculate a validated Healthy Purchasing Score (HPS; higher = healthier). A weighted genome-wide BMI genetic score was generated by summing BMI-increasing alleles.

resultsThe study included 397 adults of European ancestry (mean age, 44.9 y; 80.9% female). Participants in the highest genetic quartile (Q4) had a lower HPS and higher purchases of red-labeled items relative to participants in the lowest quartile (Q1) at baseline [Q4-Q1 Beta HPS, -4.66 (95% CI, -8.01 to -1.32); red-labeled items, 4.26% (95% CI, 1.45%-7.07%)] and at the 12-mo [HPS, -3.96 (95% CI, -7.5 to -0.41); red-labeled items, 3.20% (95% CI, 0.31%-6.09%)] and 24-mo [HPS, -3.70 (95% CI, -7.40 to 0.00); red-labeled items, 3.48% (95% CI, 0.54%-6.41%)] follow-up periods. In the intervention group, increases in HPS were similar in Q4 and Q1 at 12 mo (Q4-Q1 Beta, 1.04; 95% CI, -2.42 to 4.50). At the 24-mo follow-up, the change in BMI from baseline was similar between Q4 and Q1 (0.17 kg/m2; 95% CI, -0.55 to 0.89 kg/m2) in the intervention group, but higher in Q4 than Q1 (1.20 kg/m2; 95% CI, 0.26-2.13 kg/m2) in the control group. No interaction was evident between the treatment arm and genetic score for BMI or HPS.

conclusionsHaving a high BMI genetic risk was associated with greater increases in BMI and lower quality purchases over 2 y. The 12-mo behavioral intervention improved employees' food choices, regardless of the genetic burden, and may have attenuated weight gain conferred by having the genetic risk.

Indexed as

AdultBehavior TherapyBody Mass IndexConsumer BehaviorDiet, HealthyFemaleFood PreferencesHealth PromotionHumansMaleMiddle AgedNutritional Physiological PhenomenaObesityOccupational DiseasesPersonnel, HospitalRisk FactorsBMIdietary qualityfood qualityobesitypolygenic risk scoretraffic-light labelingweight gainworkplace intervention

Identifiers

PMID34581769
PMCPMC8755032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.